Deanol pidolate

• Description :

  Deanol pidolate (V0191; DMAE pidolate) is an orally active pro-cholinergic agent that improves cognitive symptoms by increasing the release of acetylcholine (Ach) and avoids the typical side effects of cholinesterase inhibitors. Deanol pidolate can alleviate the harmful effects of scopolamine on long-term memory and restore to baseline levels more quickly. Deanol pidolate can be used in research on Alzheimer's disease[1].

• Product Name Alternative :

  V0191; DMAE pidolate; DMAE PCA

• UNSPSC :

  12352005

• Target :

  MAChR

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Neurological Disease

• Smiles :

  O=C(O)[C@H](CC1)NC1=O.CN(CCO)C

• Molecular Formula :

  C9H18N2O4

• Molecular Weight :

  218.25

• References & Citations :

  [1]Dubois B, et al. Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease. J Alzheimers Dis. 2012;29 (3) :527-35.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [23513-72-6]